The GLP-1 Podcast Show - Dr. Christopher Kramer: Tirzepatide And Cardiovascular Health | Ep. 11

In this episode of The GLP-1 Podcast Show, Dr. Christopher Kramer, George A. Beller, MD/Lantheus Medical Imaging Distinguished Professor of Cardiovascular Medicine and Chief of the Cardiovascular Division at the University of Virginia Health, speaks with Dr. Stefan Trapp about the SUMMIT trial and the cardiovascular effects of GLP-1 and GIP therapies. The discussion explores obesity related heart failure, cardiac adipose tissue, ventricular remodeling, imaging findings, and the mechanisms behind improved cardiovascular outcomes. Listen now on all major platforms.

What you’ll learn: 

• Cardiac adipose reduction
• Heart failure outcomes
• Ventricular remodeling mechanisms
• Weight loss benefits
• Future triple agonists

Meet the guest:

Dr. Christopher Kramer earned his A.B. from Harvard and his M.D. from UCSF before completing cardiology training at the University of Pennsylvania. He is the George A. Beller, MD/Lantheus Medical Imaging Distinguished Professor of Cardiovascular Medicine and Chief of the Cardiovascular Division at the University of Virginia Health. His research focuses on cardiovascular magnetic resonance imaging and heart disease. Listen to Dr. Christopher Kramer on The GLP-1 Podcast Show, available on all major platforms.

Liked this one? Don’t stop now. Here’s what we think you’ll love!